Press release
Human Insulin Market Growth Driven by Rising Diabetes Prevalence and Technological Innovations
Human Insulin Market
A key driver of market growth is the technological advancements in diabetes care. Innovations such as recombinant DNA technology and the integration of Artificial Intelligence (AI) in production processes have enhanced productivity and energy efficiency. Additionally, the introduction of Continuous Glucose Monitoring (CGM) devices and insulin pumps has transformed insulin therapy. CGM devices allow for real-time monitoring of glucose levels, helping patients and healthcare professionals manage diabetes more effectively. Insulin pumps, which deliver insulin in a precise and controlled manner, offer significant benefits in glycemic control.
Despite these positive trends, the market faces challenges. High manufacturing costs, a shortage of skilled professionals, and strict government regulations may hinder revenue growth. The production of human insulin requires expensive equipment, making it difficult for some manufacturers to afford the necessary investments.
To Receive A PDF Sample Of The Report, Visit @https://www.emergenresearch.com/request-sample/2843
Continuous Glucose Monitoring (CGM) devices and insulin pumps represent additional technical breakthroughs revolutionizing insulin therapy. CGM devices enable real-time glucose monitoring, offering valuable insights for effective diabetes management. Similarly, insulin pumps provide precise insulin delivery, enhancing glycemic control and patient convenience.
Market Restraints
The certain factors pose challenges to market growth. Limitations in skilled workforce, high manufacturing expenses, and stringent government regulations may hinder revenue expansion. The considerable costs associated with insulin production equipment and the scarcity of proficient professionals in the field present affordability and operational constraints for manufacturers.
The global human insulin market is segmented based on product, application, and end-use. The dominance of the long-acting insulin segment is attributed to its sustained efficacy and patent protection, accounting for the largest market share in 2022. Biosimilar insulins are anticipated to register moderate growth, driven by their potential to improve patient compliance and reduce drug costs.
In terms of application, the type 1 diabetes segment is expected to hold a significant market share due to the high insulin dependency of type 1 patients, characterized as a more severe condition compared to type 2 diabetes. Conversely, the type 2 diabetes segment is projected to exhibit steady growth, fueled by the rising prevalence of the disease.
Additionally, ongoing Research & Development (R&D) efforts focus on oral insulin delivery systems, offering an alternative to insulin injections. Currently, only two systems have received FDA approval, with ORMD-0801 undergoing phase 3 clinical trials. The approval of such products presents patients with additional treatment options and enhances accessibility to insulin therapy.
To Get A Discount On The Latest Report, Visit @https://www.emergenresearch.com/request-discount/2843
In terms of end-use, the retail pharmacy segment is anticipated to dominate the market, driven by the increased accessibility of treatment options and medications. Patients find it easier to access prescribed medications and related products at local pharmacies, driving demand for these services.
Overall, the global human insulin market is on a trajectory of significant growth, propelled by the escalating prevalence of diabetes, technological advancements, and expanding treatment options. Despite challenges, the market is poised to witness substantial expansion in the coming years.
Human Insulin Top Companies and Competitive Landscape
The global human insulin market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective human insulin solutions.
Tonghua Dongbao Pharmaceutical Co., Ltd.
Eli Lilly and Company
Biocon Ltd.
Merck & Co., Inc.
Ypsomed AG
Johnson & Johnson Private Limited
Albireo Pharma, Inc.
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
WOCKHARDT
Human Insulin Latest Industry News
In November 2022, Biocon Sdn. Bhd., a subsidiary of Biocon based in Malaysia, disclosed the acquisition of a three-year contract for its recombinant human insulin brand, Insugen, awarded by the Ministry of Health (MoH) in Malaysia.
Browse Detailed Research Report @https://www.emergenresearch.com/industry-report/human-insulin-market
Human Insulin Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global human insulin market on the basis of product, application, type, end-use, and region:
Product Outlook (Revenue, USD Billion; 2019-2032)
Rapid acting insulin
Long acting insulin
Combination insulin
Biosimilar insulin
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Type 1
Type 2
Type Outlook (Revenue, USD Billion; 2019-2032)
Analog insulin
Human insulin
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospital & clinics
Retail pharmacy
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Buy Now: @https://www.emergenresearch.com/select-license/2843
Exploring Market Insights: A Guide to Related Reports
Human Insulin Market Size @ https://www.emergenresearch.com/industry-report/human-insulin-market/market-size
Human Insulin Market Share @ https://www.emergenresearch.com/industry-report/human-insulin-market/market-share
Human Insulin Market Trends @ https://www.emergenresearch.com/industry-report/human-insulin-market/market-trends
Human Insulin Regional Market Demand @ https://www.emergenresearch.com/industry-report/human-insulin-market/regional-market-demand
Human Insulin Market Analysis @ https://www.emergenresearch.com/industry-report/human-insulin-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Insulin Market Growth Driven by Rising Diabetes Prevalence and Technological Innovations here
News-ID: 3682988 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Human
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
The Human Whisperer
'The Human Whisperer'
Finlay McArthur
Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version.
The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and…
Human Physiology 2019
Human Physiology 2019
Theme: Exploring the Principles of Physiology & Metabolism
September 16-17, 2019 | London, United Kingdom
Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
